Literature DB >> 19744303

A brief history and overview of Toxoplasma gondii.

E A Innes1.   

Abstract

Toxoplasma gondii was discovered by scientists working in North Africa and Brazil around 100 years ago. The parasite has since been found to be capable of infecting all warm-blooded animals including humans making it one of the most successful parasitic organisms worldwide. The pathogenic potential of T. gondii was recognized in the 1920s and 1930s, in congenitally infected children presenting with the classic triad of symptoms, namely hydrocephalus, retinochoroiditis and encephalitis. In addition, around the same time T. gondii parasites were found to be associated with severe intraocular inflammation. In the 1980s, T. gondii emerged as a major cause of death in patients with acquired immunodeficiency syndrome, illustrating the importance of the immune system in controlling T. gondii infection. T. gondii was reported as a major cause of abortion in sheep in New Zealand in the 1950s, which raised questions about potential new transmission routes for the parasite. The discovery of the cat as the definitive host in the 1960s was a very important finding as it helped to complete our understanding of the parasite's life cycle, and the oocyst stage of T. gondii shed in the faeces of infected cats was found to be an important source of infection for many intermediate hosts and helped to explain infection in herbivorous animals and people with a vegetarian diet. In addition, this stage of the parasite was very robust and could survive in the environment, depending on the climatic conditions, for up to 12-18 months. Knowledge of the parasite's life cycle, transmission routes, risk groups and host immune responses has helped in the development of strategies to control the disease, reduce transmission of the parasite and limit environmental contamination.

Entities:  

Mesh:

Year:  2009        PMID: 19744303     DOI: 10.1111/j.1863-2378.2009.01276.x

Source DB:  PubMed          Journal:  Zoonoses Public Health        ISSN: 1863-1959            Impact factor:   2.702


  49 in total

1.  Serologic evidence that ascaris and toxoplasma infections impact inflammatory responses to Helicobacter pylori in Colombians.

Authors:  Courtney Ek; Mark T Whary; Melanie Ihrig; Luis E Bravo; Pelayo Correa; James G Fox
Journal:  Helicobacter       Date:  2012-04       Impact factor: 5.753

2.  Recombinant production, purification and crystallization of the Toxoplasma gondii coronin WD40 domain.

Authors:  Juha Pekka Kallio; Inari Kursula
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2014-03-25       Impact factor: 1.056

3.  Seroepidemiological study of toxoplasmosis in southern districts of Tamil Nadu.

Authors:  G Sucilathangam; T Anna
Journal:  J Parasit Dis       Date:  2014-08-24

4.  Synthesis and biological evaluation of 1-alkylaminomethyl-1,1-bisphosphonic acids against Trypanosoma cruzi and Toxoplasma gondii.

Authors:  Tamila Galaka; Bruno N Falcone; Catherine Li; Sergio H Szajnman; Silvia N J Moreno; Roberto Docampo; Juan B Rodriguez
Journal:  Bioorg Med Chem       Date:  2019-07-04       Impact factor: 3.641

5.  The morphological analysis of autophagy in primary skeletal muscle cells infected with Toxoplasma gondii.

Authors:  Xênia Macedo Souto; Helene Santos Barbosa; Rubem Figueiredo Sadok Menna-Barreto
Journal:  Parasitol Res       Date:  2016-04-14       Impact factor: 2.289

6.  Toxoplasma gondii meningoencephalitis without cerebral MRI findings in a patient with ulcerative colitis under immunosuppressive treatment.

Authors:  S F Assimakopoulos; V Stamouli; D Dimitropoulou; A Spiliopoulou; G Panos; E D Anastassiou; M Marangos; I Spiliopoulou
Journal:  Infection       Date:  2015-01-27       Impact factor: 3.553

7.  Seroprevalence and Associated Risk Factors for Toxoplasma gondii Infections Among Urban Poor Communities in Peninsular Malaysia.

Authors:  Norhidayu Sahimin; Izzah Ruzana Mohd Hanapi; Zarin Amalina Nurikhan; Jerzy M Behnke; Siti Nursheena Mohd Zain
Journal:  Acta Parasitol       Date:  2020-11-21       Impact factor: 1.440

8.  Design, synthesis and biological evaluation of sulfur-containing 1,1-bisphosphonic acids as antiparasitic agents.

Authors:  Marion Recher; Alejandro P Barboza; Zhu-Hong Li; Melina Galizzi; Mariana Ferrer-Casal; Sergio H Szajnman; Roberto Docampo; Silvia N J Moreno; Juan B Rodriguez
Journal:  Eur J Med Chem       Date:  2012-12-20       Impact factor: 6.514

9.  Immediate Interferon Gamma Induction Determines Murine Host Compatibility Differences between Toxoplasma gondii and Neospora caninum.

Authors:  Rachel S Coombs; Matthew L Blank; Elizabeth D English; Yaw Adomako-Ankomah; Ifeanyi-Chukwu Samuel Urama; Andrew T Martin; Felix Yarovinsky; Jon P Boyle
Journal:  Infect Immun       Date:  2020-03-23       Impact factor: 3.441

10.  Seroprevalence of toxoplasmosis, toxocariasis and cysticercosis in a rural settlement, São Paulo State, Brazil.

Authors:  Luiz Euribel Prestes-Carneiro; Guita Rubinsky-Elefant; Antonio Walter Ferreira; Patricia Regina Araujo; Charlene Troiani; Sueli Cristina Zago; Marcia Kaiahara; Leticia Sasso; Alberto Iha; Adelaide Vaz
Journal:  Pathog Glob Health       Date:  2013-03       Impact factor: 2.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.